How much funding has Biograph raised?

Biograph has raised $559.0M in total funding, most recently a Series A round.

Who are Biograph's investors?

Biograph's investors include Vy Capital, Human Capital, Alpha Wave Ventures, WndrCo, Khosla Ventures, Andreessen Horowitz.

Where is Biograph headquartered?

Biograph is headquartered in San Francisco, California, United States.

What industry is Biograph in?

Biograph operates in Healthcare, Preventive Medicine.

Biograph

Act now, live longer

San Francisco, United States · Founded 2017 · $559.0M raised

Healthcare

Preventive Medicine

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2017
Business Model: B2C

Website: biograph.com
Total Funding: $559.0M
Last Round: $559.0M Series AJan 2025
Rounds: 1

About

Biograph is the world's most advanced preventive health and diagnostics company, co-founded by longevity expert Dr. Peter Attia and entrepreneur John Hering (Vy Capital). The company collects over 1,000 data points through 30+ assessments completed in a single day — including whole-body MRI, CT coronary angiography, advanced blood panels, VO2 max testing, DEXA body composition, multi-cancer early detection, and neurocognitive testing — to build a comprehensive risk profile across the four major chronic disease pillars: heart disease, cancer, metabolic dysfunction, and neurodegeneration. Members receive a personalized care plan and ongoing clinician-led support. Biograph is backed by Vy Capital, Human Capital, Alpha Wave, and WndrCo. It operates clinics in San Francisco and New York City, with plans for further expansion.

Summary

Biograph is a Healthcare company based in San Francisco, United States, founded in 2017. It has raised $559.0M in total across 1 round, most recently a $559.0M Series A round in Jan 2025. Investors include Vy Capital, Human Capital and Alpha Wave Ventures.

LinkedIn X (Twitter)